|
|
Post by sportsrancho on Feb 12, 2018 12:34:15 GMT -5
I like watching the Shark Tank. One of the biggest advantages of having a shark on your team is that business leaders take their phone calls. If Special K calls up the heads of the insurance companies and the physician groups he will probably get through. It would be difficult for anyone else at mnkd to do that, including Mike. It should be just “Dr. K”. He has earned his credentials over his career. So that would be the respectful term for him. To late JUDY name him special K :-) and Mike’s nickname is pizza because we all know he delivers! Most of the time it’s Mike Mannkind though .. |
|
|
|
Post by uvula on Feb 12, 2018 13:17:38 GMT -5
How about "Dr. Know"?
|
|
|
|
Post by brotherm1 on Feb 12, 2018 14:01:52 GMT -5
It’s just K. OK was probably derived during President Van Buren’s re-election campaign in 1840. His nickname was Old Kinderhook and OK came to be known as abbreviation for orl korrect. Now people text K in place of OK but very few know that this special K actually originated from the Dr. Kendall for which it stands for.
|
|
|
|
Post by xanet on Feb 12, 2018 20:32:24 GMT -5
It’s just K. OK was probably derived during President Van Buren’s re-election campaign in 1840. His nickname was Old Kinderhook and OK came to be known as abbreviation for orl korrect. Now people text K in place of OK but very few know that this special K actually originated from the Dr. Kendall for which it stands for. idk... some 35 years ago my German teacher related a story he had heard years earlier from some of the old timers in Germany. They suggested that "OK" was stamped on shipping containers by some particular shipping company to indicate that the order was correct ("Ordnung Korrekt") and ready to transport. He didn't purport that that was assuredly the origin, but just mentioned what they had said. I always thought that was a fun story, and who really knows? Then again, all that was prehistoric--long before Google and the internet--so there was not yet a source for definitive truth. |
|
|
|
Post by careful2invest on Feb 13, 2018 2:21:06 GMT -5
I know the penchant for nicknames here, but at best that is a carb heavy bland breakfast cereal and probably more known by many below a certain age as the street name for an illicit drug. So it does sound like a drug pusher name, just not of a legal drug.  You're right! " Special K is the street name for the drug ketamine hydrochloride, also known as ketalar, ketaject, vitamin K, and super K. Ketamine is a legal prescription anesthetic for both people and animals, but some people use it recreationally in powder (commonly snorted, melted to inject, or taken orally) or pill (taken orally)." If thats not enough reason to not call Dr. Kendall that... Any long time listeners of the Howard Stern Show will remember that Special K was a crazy porn star that was often on his show. Dr. Kendall certainly deserves more respect than that! "Dr. Kendall" has a nice ring to it! Why not just call him that? GLTA! |
|
|
|
Post by bioexec25 on Feb 13, 2018 6:37:36 GMT -5
When not calling him Doc, I’ll just think of him as David, as in David and Goliath. He has come to slay giant pharma.
|
|
|
|
Post by dh4mizzou on Feb 13, 2018 8:11:29 GMT -5
It seems he's already addressed that as he did say "The research and clinical response to Afrezza as a mealtime insulin supports ongoing efforts to establish this product as the standard of care for those living with type 1 or type 2 diabetes," Granted the most nitpicking reader would observe it was worded that he "supports" the effort, not necessarily believing it will come to fruition. So perhaps someone should ask him if he believes it will someday be the case that Afrezza is the standard of care. That would be much stronger statement than he believes Afrezza is good... as good does not always triumph in this world. There really aren't that many "nitpickers" around here, you know. 
Well, perhaps baba on word usage. Other than him, you've earned the NP trophy, IMO.
If it's already been discussed my apologies.
What I get out of the "supports" comment is that the RESEARCH and CLINICAL RESPONSE is what is supporting the ongoing efforts.
In other words the research and clinical data dictates that this effort to establish Afrezza as the standard of care continue to be pursued.
|
|
|
|
Post by madog365 on Feb 13, 2018 11:45:47 GMT -5
Thought it was interesting that David Kendall was actually somewhat involved with Mannkind in the past - receiving funding for his research. www.medscape.org/viewarticle/706179_transcriptWhere Do Incretin-Based Therapies Fit in the Diabetes/Obesity Story? Authors: David M. Kendall, MD Faculty and Disclosures Medical Director and Chief of Clinical and Professional Services, International Diabetes Center, Associate Professor of Medicine (Clinical), University of Minnesota, Minneapolis, Minnesota Disclosure: David M. Kendall, MD, reports that he has received research grant support from Abbott Laboratories, Dexcom™ Inc, LifeScan Inc, MannKind Corporation, Medtronic Inc, Novo Nordisk A/S, and ResMed; consultant/scientific and clinical advisory board honoraria from CV Therapeutics Inc, Daiichi-Sankyo Co. Limited, HealthPartners, and Takeda Pharmaceuticals North America Inc --- DR. BUSE: It's now my pleasure to introduce Dr. David Kendall. I gave you his titles et cetera a few moments ago. He'll be talking about incretin-based therapies and where they fit into the diabetes obesity story. David is arguably, I believe at least, the premiere lecturer in clinical diabetes management. And it's going to be a great talk. You're in for a treat. David, welcome. -- A very good hire respected by peers with LOTS of connections in Diabetes space and other pharma companies. |
|
|
|
Post by nylefty on Feb 14, 2018 20:16:11 GMT -5
Job Posting On Indeed.com
Director - Medical Communications
MannKind Corporation 18 reviews - Westlake Village, CA
The Director, Medical Communications will be responsible for overseeing the medical communications functions reporting to the VP North America Medical Affairs. This individual will manage the dissemination of scientific data to health care professionals through diverse activities, including appropriate presentations at scientific meetings, educational initiatives (including grants), peer-reviewed scientific publications and balanced standard responses to provide upon unsolicited request. They will develop and manage timelines and support the efficient planning, tracking, and timely dissemination of key data and establish strong partnerships with medical thought leaders, investigators, authors, and internal cross-functional stakeholders. She/he will work closely with key stakeholders to ensure expert input and overall quality of communications, including, but not limited to, publications, abstracts, oral presentations, and publication summaries. They will oversee budget and resources to align with corporate objectives and participate in and provide strategic scientific input to the planning and execution of advisory boards, late-stage clinical trials, and external scientific communications (i.e. MSLs, speaker programs, market access, and Medical Information).
Primary Responsibilities:
Develop timelines and support the efficient planning, tracking, and timely dissemination of key data
Ensure timely publication of all R&D related primary and secondary publications including, but not limited to, manuscripts, abstracts, posters, and review articles
Lead MannKind publication planning efforts including management of publication planning agency and publication team
Manage medical communication agency to ensure accurate production specifications and timelines
Effectively manage budget and resources (vendors and agencies) to meet short- and long-term department objectives
Participate in and provide scientific input to plan and execute advisory board/consultant meetings
Interface with medical professional organizations, physicians, and specialists to define education needs for therapeutic areas
Provide therapeutic area expertise and medical to cross-functional partners (Marketing, Sales, Market Access, etc.)
Chair and manage the Medical Review Committee
Provide medical review for the medial information, educational slides and letters for healthcare professionals, and the review of marketing materials via the Promotional Review Committee process
Monitor and oversee the medical information function including the development and update of Standard Response Documents
Responsible for observing all Company, Health, Safety and Environmental guidelines.
Duties and responsibilities are not limited to the work listed above and may include other assignments as necessary
Develop and maintain all SOPs and guidance documents for all processes within professional education and publications
Medical Degree or PharmD is required plus 7 years of experience with in medical affairs in a biotech/pharmaceutical company.
Experience in leading pre-launch, launch, and post-launch activities for a new, first-in-class, or otherwise innovative product is a plus.
Knowledge of the drug development process; strong understanding of technical, business, and regulatory issues. Experience in clinical development is a plus
Be a diplomatic professional, integrating easily with the company and leadership, with the foresight and savvy to contribute to the corporate goal of becoming a leader in bringing innovative medicines to patients.
Highly motivated, decisive and results-oriented individual with the flexibility and creativity to excel in and contribute to a rapidly growing company.
Able to command respect from peers and subordinates alike, capable of highly-independent work as well as being a team player and role model. Key ability to interface with R&D and Commercial organizations.
Excellent verbal and written skills, allowing for an open and effective dialogue throughout the Company.
Ability to work independently as well as part of a team environment.
Proven ability to manage multiple projects, identify and resolve issues.
Ability to influence without authority, lead change and manage resistance to change.
Must be able to solicit information, persuade others and shape outcomes.
Must have the passion and ability to forge and nurture key partnerships and collaborations with the external scientific community, including academia, governmental organizations, nonprofit organizations and CROs.
Must be able to thrive in a fast paced environment while remaining flexible, proactive, and resourceful.
Must be able to work in a multidisciplinary environment as a leader and team member across several project team.
Ability to analyze complex issues to develop relevant and realistic plans, programs and recommendations.
Excellent written and verbal communication skills, strong problem solving ability, and attention to detail and quality are critical.
3 days ago - save job - original job
Apply Now
Other jobs you may like
Director - Medical Communications
Mannkind - Westlake Village, CA
3 days ago
|
|
|
|
Post by nylefty on Feb 14, 2018 22:38:13 GMT -5
Job Posting On Indeed.com Director - Medical Communications MannKind Corporation 18 reviews - Westlake Village, CA The Director, Medical Communications will be responsible for overseeing the medical communications functions reporting to the VP North America Medical Affairs. So WHO is this "VP North America Medical Affairs?" Dr. Kendall isn't a VP (or hasn't been announced as being one). |
|
|
|
Post by pengiep on Feb 14, 2018 22:47:19 GMT -5
Greeks will tell you that "OK" comes from Greek "ολα καλά", or "all good". I don't believe it- but that is what the Greeks told me. Ask the Greeks and they will tell you everything originated there- and they are largely correct.
|
|
|
|
Post by straightly on Feb 15, 2018 1:29:51 GMT -5
Greeks will tell you that "OK" comes from Greek "ολα καλά", or "all good". I don't believe it- but that is what the Greeks told me. Ask the Greeks and they will tell you everything originated there- and they are largely correct. Seriously!? |
|
|
|
Post by rockstarrick on Feb 15, 2018 2:51:21 GMT -5
Greeks will tell you that "OK" comes from Greek "ολα καλά", or "all good". I don't believe it- but that is what the Greeks told me. Ask the Greeks and they will tell you everything originated there- and they are largely correct. Seriously!? My History Teacher, (9th grade), would tell you the same,, but he would also tell you,, Ricks one hell of a Bass Player, if you don't believe me just ask him 😜😜 |
|
|
|
Post by patten1962 on Feb 17, 2018 21:37:34 GMT -5
The only thing I know about this man is that he is the same age as I am. I can tell you this, I would not leave a job at a big company like Lilly after so many years of working there unless something very good was in it for me.
|
|
|
|
Post by peppy on Feb 17, 2018 22:27:41 GMT -5
The only thing I know about this man is that he is the same age as I am. I can tell you this, I would not leave a job at a big company like Lilly after so many years of working there unless something very good was in it for me. What are the chances, Lilly sent him to MNKD? Exubera was Distributed by: Pfizer Labs Division of Pfizer Inc., NY, NY 10017 Lilly, lots of insulin. and monoclonal antibodies. MNKD has a patent for monoclonal antibodies. www.lilly.com/productsLilly produced a granddaddy batch of E. coli, now referred to as the "master cell bank," sometime in the 1980s. It has gone on to seed every batch of Humulin to this day. |
|
